Abivax Sa ADR (ABVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,727 | -380,266 | -297,067 | -114,410 | -55,172 |
| Depreciation Amortization | 430 | 1,213 | 930 | 595 | 288 |
| Income taxes - deferred | 267 | 6,616 | N/A | N/A | N/A |
| Accounts receivable | -4,078 | 7,967 | -2,690 | 2,596 | -2,277 |
| Accounts payable and accrued liabilities | -9,419 | -7,026 | -16,669 | 15,595 | 13,436 |
| Other Working Capital | -20,260 | 125,232 | 15,647 | 17,551 | 9,493 |
| Other Operating Activity | 30,660 | 63,962 | 138,655 | 2,448 | -827 |
| Operating Cash Flow | $-59,127 | $-182,301 | $-161,193 | $-75,625 | $-35,058 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -63 | -161 | -64 | -72 | -46 |
| Other Investing Activity | 643 | -9,109 | 5,382 | 1,512 | 1,186 |
| Investing Cash Flow | $579 | $-9,270 | $5,317 | $1,441 | $1,140 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -2,476 | -2,558 | -2,484 | -2,305 |
| Common Stock Issued | 583 | 739,872 | 760,710 | N/A | N/A |
| Other Financing Activity | -498 | -118,174 | -72,175 | -16,365 | -5,951 |
| Financing Cash Flow | $85 | $619,223 | $685,977 | $-18,849 | $-8,256 |
| Exchange Rate Effect | 8,679 | -11,598 | -10,450 | -2,026 | -738 |
| Beginning Cash Position | 604,728 | 163,172 | 168,580 | 163,720 | 151,937 |
| End Cash Position | 558,776 | 584,577 | 689,304 | 69,186 | 109,117 |
| Net Cash Flow | $-45,952 | $421,406 | $520,723 | $-94,534 | $-42,820 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,127 | -182,301 | -161,193 | -75,625 | -35,058 |
| Capital Expenditure | -63 | -161 | -64 | -72 | -46 |
| Free Cash Flow | -59,191 | -182,462 | -161,257 | -75,696 | -35,105 |